Shares of Bicara Therapeutics rose sharply in premarket trading Monday after the clinical-stage biopharmaceutical company won U.S. Food and Drug Administration breakthrough-therapy designation for its ...

MALAYSIA baru sahaja menyambut ulang tahun kemerdekaan ke-68. Seperti biasa, Jalur Gemilang berkibar megah dan program Bulan Kebangsaan berlangsung meriah sejak awal Ogos. Namun, sambutan kali ini ...

Bicara Therapeutics Inc.'s ficera had Phase 1/1b data in HPV-negative HNSCC that showed deep, durable responses, but the market reaction was negative due to Merus' competing data. Merus' petosemtamab ...

“The Rukun Negara is more than a pledge we recite. It is an enduring promise that calls us to honour our shared values in every action we take,” said Norafizal Mat Saad, vice president of group ...

The Rukun Negara, now 55 years old, remains vital in safeguarding unity and national identity, says federal minister Aaron Ago Dagang. Aaron, who is the national unity minister, stressed that the ...

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares since ...

Sultan Perak Sultan Nazrin Shah dan Raja Permaisuri Perak Tuanku Zara Salim berkenan ke Program Menyemai Semangat Kesetiaan Kepada Raja dan Negara di Bangunan Perak Darul Ridzuan Pada Sabtu/Foto RTM ...

Sultan Perak Sultan Nazrin Shah dan Permaisuri Perak Tuanku Zara Salim berkenan bergambar bersama murid-murid pada Program Menyemai Semangat Kesetiaan Kepada Raja Dan Negara Sempena Sambutan Bulan ...

KUALA LUMPUR, Aug 8 (Bernama) -- The Rukun Negara continues to be a key foundation in fostering unity and harmony in Malaysian society, especially among the youth who will lead the nation in the ...

Kumpulan pelajar membidas Ketua Setiausaha Negara (KSN) Shamsul Azri Abu Bakar kerana melarang penjawat awam menyertai demonstrasi menuntut Perdana Menteri Anwar Ibrahim meletakkan jawatan, Sabtu ini.

Bicara Therapeutics Inc. (NASDAQ:BCAX) shares are trading lower Friday following the release of updated interim data from its Phase 1/1b trial of ficerafusp alfa in combination with pembrolizumab for ...

BOSTON, May 13, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients ...